Transglutaminase 2 serves as a pathogenic hub gene of KRAS mutant colon cancer based on integrated analysis

doi:10.4251/wjgo.v16.i5.2074

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1789)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

HTML

962

Figures (1-7)

210

Tables (1-3)

159

Sum=1381

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

265

Sum=341

May 15, 2024 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. May 15, 2024; 16(5): 2074-2090
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2074

Full Size Figure Download Figure

Figure 4 Kaplan-Meier survival analysis for progression-free survival in a cohort of 158 individuals with KRAS mutant colon cancer. TGM2: Transglutaminase 2.

Citation: Peng WB, Li YP, Zeng Y, Chen K. Transglutaminase 2 serves as a pathogenic hub gene of KRAS mutant colon cancer based on integrated analysis. World J Gastrointest Oncol 2024; 16(5): 2074-2090
URL: https://www.wjgnet.com/1948-5204/full/v16/i5/2074.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.2074